Form D · Pharmaceuticals
Citius Pharmaceuticals, Inc.
Cranford, NJ · CIK 0001506251
Offering snapshot reported Feb 1, 2021 · SEC filing
- Reported sold
- $20M Offering amount: $20M
- Investors reported
- 7 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 27, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 1, 2021 | Initial | $20,000,012 | No comparison | 7 | SEC filing |
| May 19, 2020 | Initial | $220,588 | No comparison | 5 | SEC filing |
| Apr 8, 2019 | Initial | $428,803 | No comparison | 3 | SEC filing |
| May 22, 2018 | Initial | $83,688 | No comparison | 2 | SEC filing |
| Dec 20, 2017 | Initial | $40,011 | No comparison | 8 | SEC filing |
| Feb 27, 2017 | Amendment | $549,900 | $159,900vs Dec 8, 2016 | 9 | SEC filing |
| Dec 8, 2016 | Initial | $390,000 | No comparison | 5 | SEC filing |
| Oct 26, 2011 | Initial | $8,000 | No comparison | 29 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $1.4M
- Finders' fees
- $0
- Form D file number
- 021-387992
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| H.C. Wainwright & Co., LLC | 375 | H.C. Wainwright & Co., LLC · CRD 375 |
Source: Form D, filed Feb 1, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jaime Bartushak | Executive |
| Suren Dutia | Director |
| Myron Holubiak | Director, Executive |
| Eugene Holuka | Director |
| William Kane | Director |
| Leonard Mazur | Director, Executive |
| Ralph Montrone | Director, Executive |
| Howard Safir | Director |
| Carol Webb | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
11 Commerce Drive First Floor
Cranford, NJ, 07016
Cranford, NJ, 07016